Bortezomib With Melphalan and Prednisone for Multiple Myeloma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of bortezomib in combination with
melphalan and prednisone to achieve complete responses for patients with previously untreated
multiple myeloma compared to an historical control group. This trial will also evaluate the
safety and toxicity of this regimen as well as evaluate the duration of response of this
regimen.